Bridgett Goodwin

Health Outcomes Research in Cambridge Ma

Role
Heor Team Lead Rare Gi and Sten Cell Therapy at Takeda
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Bridgett Goodwin

Experienced Global and US Director HEOR with a demonstrated history of providing patient and payer focused outcomes research support from early development through post launch of products in the pharmaceuticals industry. Skilled in Retrospective database studies, Market Access and Payer Strategy, Health Technology Assessment (HTA), and Managed Care. Strong research professional with broad therapeutic experience.

Experience

  1. Heor Team Lead Rare Gi and Sten Cell Therapy

    Takeda

    May 2018 — Present · Cambridge, MA, US

    Supporting GI w/i Rare Diseases and Internal Medicine

Education

  • West Virginia University

    Bachelor of Science (BS)

  • University of Vermont

    Masters, Biostatistics

    1989 — 1991

  • The University of North Carolina at Chapel Hill

    School of Public Health PhD, Health Services Research

    1994 — 1999

Skills

  • Health Outcomes
  • Managed Care
  • Clinical Development
  • Neuroscience
  • Life Sciences
  • Pharmacoeconomics
  • Clinical Trials
  • Pharmaceutical Industry
  • Fda
  • Medical Writing
  • Biostatistics
  • Healthcare
  • Health
  • Oncology
  • Informatics
  • Biotechnology
  • Outcomes Research
  • Market Access
  • Health Economics
  • Diabetes
  • Infectious Diseases
  • Drug Development
  • Pharmacoepidemiology
  • Clinical Research
  • Hta
  • Epidemiology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Bridgett Goodwin — Heor Team Lead Rare Gi and Sten Cell Therapy at Takeda in Cambridge, MA, US | Unifers